| Dr Michael Hede Watanabe, PHARM D | |
|
4201 W Chapman Ave, Orange, CA 92868-1505 | |
| (714) 748-6333 | |
| (714) 748-6334 |
| Full Name | Dr Michael Hede Watanabe |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4201 W Chapman Ave, Orange, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669551123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH30243 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Hede Watanabe, PHARM D 2181 Marselina, Tustin, CA 92782 Ph: (714) 832-9790 | Dr Michael Hede Watanabe, PHARM D 4201 W Chapman Ave, Orange, CA 92868-1505 Ph: (714) 748-6333 |
News Archive
SpectraScience has announced that it has filed for a new patent with the United States Patent and Trademark Office.
Parkinson's disease (PD) is a lifelong condition that affects the nerve cells in the brain that produce dopamine. As a result, people with this neurodegenerative disease experience tremors, changes in speech, gait issues, and muscle rigidity. Though it has no cure, a new drug used to treat cancer shows promise in treating Parkinson's.
HerKare opens a new location today in Mansfield, Texas. This marks HerKare's third center in Dallas-Fort Worth. HerKare recently expanded to Houston area and continues to accelerate their growth plans, making the treatment of hormonal imbalance in women more convenient.
LifeMap Solutions, Inc., a medical technology startup focused on creating innovative mobile health (mHealth) products and services powered by big data, today announced an initial $5 million seed round led by parent company LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., with additional participation via in-kind support from its development partner, the Icahn School of Medicine at Mount Sinai.
Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, today announced that it has begun enrolling patients in a Phase 2 clinical trial of its lead compound, JVRS-100, as an adjuvant for seasonal influenza vaccines in the elderly population.
› Verified 9 days ago
Joanne S Lau, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 City Pkwy W Ste 800, Orange, CA 92868 Phone: 714-347-5858 | |
Ali Shishehgar, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 132 S Anita Dr Ste 310, Orange, CA 92868 Phone: 877-778-3773 | |
Mrs. Stephanie Tram Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 W La Veta Ave, Orange, CA 92868 Phone: 714-509-8856 Fax: 714-509-4371 | |
Travis Stucky, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1538 E Chapman Ave, Orange, CA 92866 Phone: 714-288-1790 | |
Dr. William Robert Truong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8000 | |
Christine Jung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 City Pkwy W Ste 800, Orange, CA 92868 Phone: 657-236-5153 Fax: 714-560-7627 | |
Terrie Liu Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8968 |